Gen Pharmaceuticals
Focus: Gen Pharmaceuticals is a Turkish-based generic and branded small-molecule pharmaceutical company focused on cardiovascular, neurology, musculoskeletal, immunology, and metabolic disease indications. The company operates primarily in the post-LOE generic market with significant Part D revenue concentration.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
Recent layoff filing — 45 affected
- 7/7/2025 — RIVIERA BEACH, FL · 45 affected · Layoff Amendment
Source: state DOL filings via Big Local News
About Gen Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Gen Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$129M Part DDeclining
Post-LOE
Flagship revenue driver representing 50% of company revenue; mature calcium channel blocker in highly competitive generic space.
Help build intelligence for Gen Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.